Sign in
TerminatedNo phase

Long COVID-19 Rehabilitation & Recovery Research Program

Key facts

Who runs it
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Where
Torrance, United StatesSee the site
Trial code
Status
Terminated
People taking part
21 people enrolled
Started
2 Feb 2022
Ended
31 Dec 2023
Type of study
Interventional
Treatments tested
  • On Site Exercise Rehabilitation
Record updated
22 September 2025
Why it stopped
Funding exhausted.

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Long COVID-19 Infection (Documented by PCR or patient report)
  • Age >= 18 years old
  • At least 12 weeks since the initial COVID Infection
  • One or more of the following symptom/signs: Fatigue, Dyspnea, Exercise Intolerance, Post Exertional Malaise and/or Difficulty Breathing
  • Able to perform a cardiopulmonary exercise test

Who cannot take part

  • Patients who have completed a pulmonary rehabilitation program in the six weeks prior to the screening visit or patients who are currently in a pulmonary rehabilitation program
  • Patients who have taken an investigational drug within one month or six half-lives (whichever is greater) prior to screening visit (Visit 1)
  • Malignancy for which the patient has undergone resection, radiation therapy, or chemotherapy within the last 2 years
  • Any other significant disease than COVID-19 which, in the opinion of the investigator, may i) put the patient at risk because of participation in the study, ii) influence the results of the study (e.g. Insulin or testosterone therapy, systemic corticosteroids, HIV, etc), iii) cause concern regarding the patient's ability to participate in the study
  • Patients is not able to perform technically acceptable pulmonary function tests and symptom-limited cardiopulmonary cycle ergometry tests
  • Patients who desaturate to SpO2 <80% on screening incremental exercise testing
  • Pregnant or nursing women
  • Women of childbearing potential who are not using a highly effective method of birth control. Female patients will be considered of childbearing potential unless surgically sterilized by hysterectomy or bilateral tubal ligation, or post-menopausal for at least two years
  • Patients who are currently participating in another interventional study

Where in United States

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterTorrance, United States

About the trial

What the trial wants to find out

The purpose of the study is to assess the physiologic, immunologic, and mental health effects of an exercise and pulmonary rehabilitation program on patients with Long COVID-19 (LC).

The group in the trial

  • +/- PEMTreatment being tested

    Patients with and without Post Exertional Malaise (PEM) will receive 10 weeks of on site low to moderate intensity exercise rehabilitation.

    Treatment: On Site Exercise Rehabilitation

Results explained

A paper that names this trial, explained in plain words.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Long COVID-19 Rehabilitation & Research Program
Publications
Record updated
22 September 2025